Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?-Reference-Cited by-同舟云学术

Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?

Published:2013-06-03 Issue:11 Volume:15 Page:1022-1028
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Nagendran J.,Oudit G. Y.,Bakal J. A.¹,Light P. E.²,Dyck J. R. B.,McAlister F. A.¹

Affiliation:

1. Division of General Internal Medicine and Patient Health Outcomes Research and Clinical Effectiveness Unit, Department of Medicine; University of Alberta; Edmonton; Alberta; Canada

2. Department of Pharmacology; University of Alberta; Edmonton; Alberta; Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12126/fullpdf

Reference23 articles.

1. Cardiovascular effects of diabetes drugs: emerging from the dark ages;Nissen;Ann Intern Med,2012

2. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study;Roumie;Ann Intern Med,2012

3. Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention-a retrospective nationwide cohort study;Jorgensen;Cardiovasc Diabetol,2010

4. The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus;Lexis;Cardiovasc Diabetol,2009

5. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction;Garratt;J Am Coll Cardiol,1999

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study;Diabetes, Obesity and Metabolism;2024-09-09

2. Toxicity of Metformin and Hypoglycemic Therapies;Advances in Chronic Kidney Disease;2020-01

3. GLP‐1 Is a Coronary Artery Vasodilator in Humans;Journal of the American Heart Association;2018-11-20

4. The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?;Current Diabetes Reports;2017-10-23

5. Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies;Diabetes Care;2017-04-20